| DESCRIPTION |
-
- INTRODUCTION OF BLINATUMOMAB ANTINEOPLASTIC IMMUNOTHERAPY INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH, NEW TECHNOLO-GY GROUP 1
-
- Introduction of Blinatumomab Antineoplastic Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 1
|